AMGN
AMGEN Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, recognized for its pioneering therapies developed through recombinant DNA technology. The company focuses on key therapeutic areas including oncology, nephrology, and inflammation, utilizing i...
$465.67
-0.30% ($1.39)
Volume
2.12M
52W High
$483.99
52W Low
$312.39
Market Cap
$251.64B
Next Earnings Report
Last Reported
Nov 3, 2026 Beat
Actual: $6.45
vs. Consensus: $5.74
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q3 2026
Nov 3, 2026
1-Day:
+3.73%
Q2 2026
Aug 4, 2026
1-Day:
+4.57%
Q1 2026
Apr 30, 2026
1-Day:
-4.75%
5-Day:
-4.81%
Q1 2026
Apr 29, 2026
1-Day:
+2.43%
5-Day:
-4.19%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'26 | $10.37B | +8.5% | 73.1% | 35.8% | $3.86B |
| Q2'26 | $10.05B | +9.7% | 72.0% | 35.0% | $2.38B |
| Q1'26 | $8.62B | +5.8% | 68.2% | 30.9% | $1.82B |
| Q4'25 | $9.90B | +8.9% | 81.9% | 39.8% | $1.33B |
| Q3'25 | $9.56B | +12.4% | 67.8% | 26.4% | $3.22B |
| Q2'25 | $9.17B | +9.3% | 67.2% | 28.8% | $1.43B |
| Q1'25 | $8.15B | +9.4% | 63.6% | 14.5% | $1.73B |
| Q4'24 | $9.09B | +10.9% | 65.8% | 25.4% | $627.0M |
Company Information
Symbol
AMGN
Company
AMGEN Inc
Market Cap
$251.64B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare AMGN with competitors
Side-by-side earnings comparison